HIV/AIDS News and Research

RSS

Acquired immune deficiency syndrome or acquired immunodeficiency syndrome (AIDS) is a disease of the human immune system caused by the human immunodeficiency virus (HIV).

Diplomat Specialty Pharmacy to help patients obtain financial assistance to purchase life-saving drugs

Diplomat Specialty Pharmacy, the nation's largest privately held specialty pharmacy company, is on a mission to help patients obtain the financial assistance they need to purchase life-saving drugs for such illnesses as cancer, HIV/AIDS and Hepatitis C, as well as drugs for Multiple Sclerosis, kidney disease and other chronic conditions.

4 Mar 2010

Mosaic vaccines show promise in reducing HIV spread

Two teams of researchers-including Los Alamos National Laboratory theoretical biologists Bette Korber, Will Fischer, Sydeaka Watson, and James Szinger-have announced an HIV vaccination strategy that has been shown to expand the breadth and depth of immune responses in rhesus monkeys. Rhesus monkeys provide the best animal model currently available for testing HIV vaccines.

4 Mar 2010

New book on role of CBOs and NGOs in global public health

Igniting the Power of Community: The Role of CBOs and NGOs in Global Public Health is a new book edited by Paul Gaist, PhD, MPH, adjunct professor at the Johns Hopkins Bloomberg School of Public Health, which explores the pursuits and potential of community-based organizations (CBOs) and nongovernmental organizations (NGOs) to transform global public health.

4 Mar 2010

UNAIDS launches plan to address gender equality, HIV/AIDS

UNAIDS on Tuesday launched a five-year initiative to help tackle gender inequalities and human rights violations that increase the vulnerability of women worldwide to HIV/AIDS, BBC reports (3/3).

4 Mar 2010

Abbott enters into agreement with GSK to develop molecular diagnostic test for skin cancer treatment

Abbott announced today that it has entered into an agreement with GlaxoSmithKline (GSK) to develop a molecular diagnostic test intended for use as an aid in selecting patients who may benefit from a skin cancer treatment in development by GSK.

4 Mar 2010

Also in Global Health News: U.S. Ambassador to U.N.; Male circumcision; River blindness in Ecuador; Nursing shortage in Caribbean; Maternal health in Bolivia; Drug-resistant TB in North Korea; Cholera vaccine

Betty King reported to her new position as U.S. ambassador to the U.N. in Geneva on Wednesday, the Associated Press reports. "Washington's Geneva mission had been without an ambassador since Warren W. Tichenor left his post on Jan. 20, 2009 - when Barack Obama was sworn in as president," according to the news service (3/3).

4 Mar 2010

Elsevier releases special issue to mark the 25th anniversary of antiretroviral drug development

Elsevier, the world-leading publisher of scientific, technical and medical information products and services, released a special issue of the journal Antiviral Research (www.sciencedirect.com/science/journal/01663542), marking the 25th anniversary of antiretroviral drug development.

4 Mar 2010

Meeting addresses how to improve HIV/AIDS surveillance in Asia

A five-day workshop that opened Monday in Ho Chi Minh City, Vietnam, will address ways to improve HIV/AIDS surveillance in the Asia region, Viet Nam News reports.

4 Mar 2010

Study on role of recorded ODLs in improving clinical care for low-weight babies: RWJF awards $480,000 grant

Researchers at Charles Drew University of Medicine and Science and UC Irvine will monitor the day-to-day health of low-birth-weight babies and their parents as part of a comprehensive initiative designed to combat chronic illnesses associated with low-weight births.

4 Mar 2010

Winner of 2010 Thomas Parran Award

University of Washington's Dr. H. Hunter Handsfield, a long-time trailblazer in sexually transmitted diseases (STD) research, will receive the nation's highest honor in the STD field during the Centers for Disease Control and Prevention's 2010 National STD Prevention Conference in Atlanta, March 8-11.

3 Mar 2010

AHF’s Magic Johnson ‘Testing America’ Tour arrives in Columbia, South Carolina to host free HIV testing events

AHF’s Magic Johnson ‘Testing America’ Tour, a six month, 48 state national cross country HIV testing tour, arrives in Columbia, South Carolina to host free HIV testing events, along with local partner South Carolina HIV/AIDS Council, today and tomorrow, March 3rd and 4th from 10:00 am to 5:00 pm. All are welcome to attend.

3 Mar 2010

Genetic Immunity to present data on DermaVir for HIV/AIDS at DNA Vaccines 2010

Genetic Immunity, a US/Hungarian biopharmaceutical company developing nanomedicine vaccines, will present data at this week’s DNA Vaccines 2010 in New Orleans, LA concerning the formulation and topical administration of the DermaVir therapeutic vaccine for HIV/AIDS. DNA Vaccine 2010 invites leading scientists to report on the latest research in the progressive field of DNA or Genetic Vaccines.

3 Mar 2010

Merck announces updated late-stage pipeline following its recent merger with Schering-Plough

Merck & Co., Inc. today announced its updated, newly integrated, late-stage pipeline following its recent merger with Schering-Plough. The new pipeline features a broad and diversified portfolio of investigational medicines and vaccines, including more than 20 candidates in Phase III or under regulatory review, and more than 20 candidates in Phase II of development.

3 Mar 2010

Inovio Biomedical introduces new CELLECTRA-SP series of hand-held, cordless electroporation devices

Inovio Biomedical Corporation, a leader in DNA vaccine design, development and delivery, has unveiled its new CELLECTRA®-SP series of hand-held, cordless electroporation devices at the DNA Vaccines 2010 conference being held in New Orleans, LA.

3 Mar 2010

Aggressive treatment of anemia with ESAs may lower risk of death for dialysis patients: Study

Aggressive treatment of anemia with intravenous iron and drugs known as erythropoiesis-stimulating agents (ESAs) may lower the risk of death for dialysis patients with severe anemia - but also may increase the risk of death among patients with milder anemia, a new study led by a University of North Carolina at Chapel Hill epidemiologist suggests.

3 Mar 2010

Biomagnetics Diagnostics announces accelerated delivery timetable for integrated optical biosensor

Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis and malaria detection, today announced its accelerated timetable for delivery of the world's first handheld, integrated optical biosensor.

3 Mar 2010

Bisphosphonates may lower risk of breast cancer

Women who take some types of bone-building drugs used to prevent and treat osteoporosis may be at lower risk of breast cancer, according to a study by U.S. researchers published today in the British Journal of Cancer.

3 Mar 2010

Ichor, Profectus announce agreement for clinical development of DNA vaccine programs

Ichor Medical Systems (Ichor) and Profectus Biosciences (Profectus) announced today that they have entered into a long-term development, license, and supply Agreement providing Profectus with commercial access to Ichor’s TriGrid™ Delivery System (TriGrid™) for the clinical development of its DNA vaccine programs, with an option for Ichor to co-develop.

3 Mar 2010

State roundup: Mass. hospital controversy, Iowa and Utah consider coverage expansions

The state appealed to the federal government yesterday to help Massachusetts hospitals that care for disproportionately high numbers of lower-income patients who receive state-sponsored health insurance. Governor Deval Patrick is asking the Obama administration for $216 million for Cambridge Health Alliance, the state's only public acute-care hospital, and another $115 million for six private hospitals with high Medicaid patient populations

3 Mar 2010

HIV, NCDs impact achievement of MDGs, study says

Unequal progress in achieving U.N. Millennium Development Goals (MDGs) for tuberculosis and child mortality in low-income countries is related to the countries' burdens of HIV and non-communicable diseases (NCD), according to a study published Tuesday in the journal PLoS Medicine, Reuters reports (Kelland, 3/2).

3 Mar 2010

HIV/AIDS News and Research

Further Reading

Diplomat Specialty Pharmacy to help patients obtain financial assistance to purchase life-saving drugs

Mosaic vaccines show promise in reducing HIV spread

New book on role of CBOs and NGOs in global public health

UNAIDS launches plan to address gender equality, HIV/AIDS

Abbott enters into agreement with GSK to develop molecular diagnostic test for skin cancer treatment

Also in Global Health News: U.S. Ambassador to U.N.; Male circumcision; River blindness in Ecuador; Nursing shortage in Caribbean; Maternal health in Bolivia; Drug-resistant TB in North Korea; Cholera vaccine

Elsevier releases special issue to mark the 25th anniversary of antiretroviral drug development

Meeting addresses how to improve HIV/AIDS surveillance in Asia

Study on role of recorded ODLs in improving clinical care for low-weight babies: RWJF awards $480,000 grant

Winner of 2010 Thomas Parran Award

AHF’s Magic Johnson ‘Testing America’ Tour arrives in Columbia, South Carolina to host free HIV testing events

Genetic Immunity to present data on DermaVir for HIV/AIDS at DNA Vaccines 2010

Merck announces updated late-stage pipeline following its recent merger with Schering-Plough

Inovio Biomedical introduces new CELLECTRA-SP series of hand-held, cordless electroporation devices

Aggressive treatment of anemia with ESAs may lower risk of death for dialysis patients: Study

Biomagnetics Diagnostics announces accelerated delivery timetable for integrated optical biosensor

Bisphosphonates may lower risk of breast cancer

Ichor, Profectus announce agreement for clinical development of DNA vaccine programs

State roundup: Mass. hospital controversy, Iowa and Utah consider coverage expansions

HIV, NCDs impact achievement of MDGs, study says

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News